ShareThis Page

Another UPMC mold death spurs new lawsuit

Ben Schmitt
| Tuesday, Feb. 14, 2017, 10:01 a.m.
John R. Haines.
John R. Haines.
The UPMC sign atop the U.S. Steel Tower in downtown Pittsburgh.
The UPMC sign atop the U.S. Steel Tower in downtown Pittsburgh.

Another lawsuit against UPMC surrounding the fatal mold crisis was filed Tuesday in connection with the October death of an Upper St. Clair man.

Lawyers for the family of John R. Haines, 65, also are suing the health system's linen supplier, Paris Healthcare Linen Services of DuBois.

The newest lawsuit targets a new hospital, UPMC Shadyside, with allegations of negligence, medical malpractice and wrongful death. The previous incidents in which organ transplant patients suffered fungal infections were contained to UPMC Presbyterian and Montefiore hospitals.

On Oct. 5, after several weeks of chemotherapy treatment, he was diagnosed with a rhizopus fungal infection, his lawyers said. He died Oct. 7. A death certificate lists his causes of death as cardiac arrest, sepsis and rhizopus fungal pneumonia.

Haines is the sixth person believed to have died after contracting a fungal infection inside a UPMC facility.

However, the lawsuit pointed out that there is an additional case of an unnamed patient who died at UPMC Shadyside in 2015 after contracting a fungal infection.

UPMC officials said Haines was extremely sick when he was admitted to Shadyside. He had tested positive for pseudomonas, an often deadly bacteria, and was diagnosed with leukemia. His immune system was not functioning, UPMC said in an emailed response Tuesday.

"It is critically important to understand that rhizopus is present in all environments and does not cause illness in anyone except for those with the most severely compromised immune systems," the UPMC statement said. " Despite our best protocols, it can still be carried into the hospital on the shoes or clothes of visitors."

UPMC explained to his family that Haines, an avid gardener, might have contracted the fungal infection prior to his hospitalization, the statement said.

"We decided, however, to classify it as hospital-acquired per CDC (Centers for Disease Control and Prevention) guidelines even though clinically there can be no certainty," officials said. "We have tested hospital linens at UPMC Shadyside and found no rhizopus."

At the time of his initial admission, Haines did not have any kind of fungal infection, according to Pittsburgh attorneys Brendan Lupetin and Jerry Meyers.

"Fungus is everywhere, that's true," Meyers said. "But I'll tell you one place it shouldn't be. It shouldn't be in operating rooms. It shouldn't be in ICUs. It's everywhere which is why there's a diligent effort in hospitals all over the United States who do work on immune-compromised people to protect them."

Paris CEO Dave Stern issued a statement saying the company consistently meets or exceeds accreditation standards and regulatory guidelines for laundering linens.

"We continue to cooperate with all regulatory agencies involved in the oversight of linen processing," he said. "The Centers for Disease Control and Prevention and the Pennsylvania Department of Health both reviewed the facts in this case. Neither agency identified linens as the source of the problem."

Haines was diagnosed with acute leukemia and bacterial pneumonia when he was transferred from St. Clair Hospital in Mt. Lebanon to UPMC Shadyside in September, the lawsuit states.

"At all times relevant hereto, Defendant UPMC and Defendant Paris knew or should have known that fungi like rhizopus, thrive, proliferate and reproduce best in moist/damp environments," the lawsuit stated.

On the day of his death, his family received a letter from UPMC patient safety officer Lisa Donahue.

The letter said, "During your stay, you developed an infection in addition to the infection you presented with to UPMC Shadyside. This was identified by positive culture results and/or symptoms you may have experienced."

The case filed in Allegheny County Court of Common Pleas marks the fifth known lawsuit connected to mold deaths in organ transplant patients that surfaced in September 2015. Two lawsuits have been settled for $1.35 million apiece.

An internal UPMC report that surfaced last month indicated heavy mold growth was found in linens delivered to UPMC Montefiore.

UPMC hired Andrew Streifel, a hospital environment specialist with the University of Minnesota's department of environmental health and safety, to investigate Paris Healthcare Linen Services.

As part of the investigation, Streifel inspected a linen cart delivered by Paris to UPMC Montefiore on Feb. 2, 2016. Samples showed "heavy fungal growth" of rhizopus on the "wet sheets collected from the UPMC laundry carts," he wrote in the report. He also found rhizopus mold at the Paris facility and on its roof.

In a Jan. 27 interview with the Tribune-Review, Streifel said he believes laundry was the source of fungal infections that killed transplant patients.

"The test was very conclusive for fungus," he said at the time. "It was also conclusive that something was wrong with that laundry."

Streifel's report, which the medical center received in May 2016, was filed last month in two wrongful-death lawsuits brought against the hospital system by the families of the deceased. Those lawsuits, filed on behalf of families of Che DuVall, 70, of Perryopolis, and Daniel Krieg, 56, of St. Marys, also added Paris as a new defendant.

Paris has denied any wrongdoing.

Despite the new report regarding Paris, the Centers for Disease Control and Prevention, has said it's not taking any further action. Neither is the Pennsylvania Department of Health.

"Why you hire someone to investigate and then disregard what they say, I don't understand," Meyers said of UPMC and Streifel. "Their investigator told them, 'It's the linen.'"

Lupetin said it's imperative that the CDC comes back and investigates further.

"Here is another case," he said Haines. "Here is another type of immune-suppressed patient that needlessly developed this very, very, very rare type of fungal infection. And we expect there will be more in the future. So let's get to the bottom of this. Let's get the CDC back. Let's get a definite and answer to make sure that this doesn't continue to happen to more patients."

Ben Schmitt is a Tribune-Review staff writer. Reach him at 412-320-7991 or

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.